Phospholipid transfer protein, an emerging cardiometabolic risk marker: Is it time to intervene?

被引：13
作者：
Dullaart, R. P. F. [1 ,2 ]
van Tol, A. [1 ,2 ,3 ]
Dallinga-Thie, G. M. [4 ,5 ]
机构：
[1] Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, NL-9700 RB Groningen, Netherlands
[3] Erasmus Univ, Dept Cell Biol & Genet, Med Ctr, NL-3000 DR Rotterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands
来源：
ATHEROSCLEROSIS | 2013年 / 228卷 / 01期
关键词：
PLTP; CVD risk; CHOLESTERYL ESTER TRANSFER; TYPE-2; DIABETES-MELLITUS; APOLIPOPROTEIN-B SECRETION; PLASMA PLTP ACTIVITY; CONTAINING LIPOPROTEINS; CARDIOVASCULAR-DISEASE; MASS; ATHEROSCLEROSIS; MICE; DEFICIENCY;
D O I：
10.1016/j.atherosclerosis.2013.01.043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：38 / 41
页数：4
相关论文
共 37 条
[1]   Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism [J].
Albers, John J. ;
Vuletic, Simona ;
Cheung, Marian C. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2012, 1821 (03) :345-357
[2]   Plasma PLTP activity is inversely associated with HDL-C levels [J].
Chen, Xueying ;
Sun, Aijun ;
Mansoor, Ather ;
Zou, Yunzeng ;
Ge, Junbo ;
Lazar, Jason M. ;
Jiang, Xian-Cheng .
NUTRITION & METABOLISM, 2009, 6
[3]   Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification [J].
Colhoun, HM ;
Scheek, LM ;
Rubens, MB ;
Van Gent, T ;
Underwood, SR ;
Fuller, JH ;
Van Tol, A .
DIABETES, 2001, 50 (03) :652-659
[4]   Plasma pre β-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein [J].
Dallinga-Thie, G. M. ;
van Tol, A. ;
Dullaart, R. P. F. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2009, 1791 (08) :714-718
[5]   Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins [J].
Dallinga-Thie, Geesje M. ;
Dullaart, Robin P. F. ;
van Tol, Arie .
CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (03) :251-257
[6]   Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus [J].
de Vries, R ;
Dallinga-Thie, GM ;
Smit, AJ ;
Wolffenbuttel, BHR ;
van Tol, A ;
Dullaart, RPF .
DIABETOLOGIA, 2006, 49 (02) :398-404
[7]   Plasma phospholipid transfer protein activity is independently determined by obesity and insulin resistance in non-diabetic subjects [J].
de Vries, Rindert ;
Kappelle, Paul J. W. H. ;
Dallinga-Thie, Geesje M. ;
Dullaart, Robin P. F. .
ATHEROSCLEROSIS, 2011, 217 (01) :253-259
[8]   Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA [J].
Desrumaux, C ;
Athias, A ;
Bessède, G ;
Vergès, B ;
Farnier, M ;
Perségol, L ;
Gambert, P ;
Lagrost, L .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (02) :266-275
[9]   Plasma Phospholipid Transfer Protein Deficiency in Mice Is Associated With a Reduced Thrombotic Response to Acute Intravascular Oxidative Stress [J].
Desrumaux, Catherine ;
Deckert, Valerie ;
Lemaire-Ewing, Stephanie ;
Mossiat, Claude ;
Athias, Anne ;
Vandroux, David ;
Dumont, Laure ;
Monier, Serge ;
de Barros, Jean-Paul Pais ;
Klein, Alexis ;
De Maistre, Emmanuel ;
Blache, Denis ;
Beley, Alain ;
Marie, Christine ;
Garnier, Philippe ;
Lagrost, Laurent .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (12) :2452-U225
[10]   Type 2 diabetes mellitus interacts with obesity and common variations in PLTP to affect plasma phospholipid transfer protein activity [J].
Dullaart, R. P. F. ;
Vergeer, M. ;
de Vries, R. ;
Kappelle, P. J. W. H. ;
Dallinga-Thie, G. M. .
JOURNAL OF INTERNAL MEDICINE, 2012, 271 (05) :490-498
1234